BIOMARKER:

Chr t(4;9;22)(q21;q34;q11)

Chr t(4;9;22)(q21;q34;q11) Chr t(4;9;22)(q21;q34;q11)	Chronic Myeloid Leukemia CML	nilotinib Sensitive: C4 – Case Studies
Chr t(4;9;22)(q21;q34;q11) Chr t(4;9;22)(q21;q34;q11)	Multiple Myeloma Multiple Myeloma	nilotinib Sensitive: C4 – Case Studies

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

Associations